Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Intense exercise is a major challenge to the management of type 1 diabetes (T1D). Closed-loop control (CLC) systems (artificial pancreas) improve glycemic control during limited intensity and short duration of physical activity (PA). However, CLC has not been tested during extended vigorous outdoor exercise common among adolescents. RESEARCH DESIGN AND METHODS: Skiing presents unique metabolic challenges: intense prolonged PA, cold, altitude, and stress/fear/excitement. In a randomized controlled trial, 32 adolescents with T1D (ages 10–16 years) participated in a 5-day ski camp (∼5 h skiing/day) at two sites: Wintergreen, VA, and Breckenridge, CO. Participants were randomized to the University of Virginia CLC system or remotely monitored sensor-augmented pump (RM-SAP). The CLC and RM-SAP groups were coarsely paired by age and hemoglobin A1c (HbA1c). All subjects were remotely monitored 24 h per day by the study physicians and clinical team. RESULTS: Compared with physician-monitored open loop, percent time in range (70–180 mg/dL) improved using CLC: 71.3 vs. 64.7% (+6.6% [95% CI 1–12]; P = 0.005), with maximum effect late at night. Hypoglycemia exposure and carbohydrate treatments were improved overall (P = 0.001 and P = 0.007) and during the daytime with strong ski level effects (P = 0.0001 and P = 0.006); ski/snowboard proficiency was balanced between groups but with a very strong site effect: naive in Virginia and experienced in Colorado. There was no adverse event associated with CLC; the participants’ feedback was overwhelmingly positive. CONCLUSIONS: CLC in adolescents with T1D improved glycemic control and reduced exposure to hypoglycemia during prolonged intensive winter sport activities, despite the added challenges of cold and altitude.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and (3) the first”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [128]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Automated insulin delivery systems can potentially modify insulin dosing in response to activity monitors to reduce the risk (or severity) of exercise-induced hypoglycemia in people living with type 1 diabetes [7-10].”
From Accuracy of Wrist-Worn Activity Monitors During Common Daily Physical Activities and Types of Structured Exercise: Evaluation Study (2018) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254
Self-citationSafety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., Balliro, C., Hillard, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 602
Weinzimer, S. A., Steil, G. M., Swan, K. L., Dziura, J., Kurtz, N., & Tamborlane, W. V. (2008) · Diabetes Care · doi:10.2337/dc07-1967 · Cited by 567
Hovorka, R., Allen, J. M., Elleri, D., Chassin, L. J., Harris, J., Xing, D., Kollman, C., Hovorka, T., Larsen, A. M. F., Nodale, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61998-x · Cited by 450 · cited 2×
“control while decreasing the rates of hyperglycemia and hypoglycemia in inpatient trials (5,10,11), at diabetes camps”
BackgroundMethodHome Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp
Phillip, M., Battelino, T., Atlas, E., Kordonouri, O., Bratina, N., Miller, S., Biester, T., Avbelj Stefanija, M., Muller, I., Nimri, R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206881 · Cited by 435 · cited 1×
“There have also been several older studies investigating the role of overnight glucose control with AP in a camp setting (13,26) that confirmed the trend of re-”
BackgroundClosed-Loop Artificial Pancreas Systems: Engineering the Algorithms
Doyle, F. J., Huyett, L. M., Lee, J. B., Zisser, H. C., & Dassau, E. (2014) · Diabetes Care · doi:10.2337/dc13-2108 · Cited by 394 · cited 1×
“CLC systems involve the pairing of a continuous subcutaneous insulin infusion pump and a continuous glucose monitor (CGM) with a CLC algorithm that automatically adjusts insulin infusion in real time (4).”
BackgroundComing of age: the artificial pancreas for type 1 diabetes
Thabit, H., & Hovorka, R. (2016) · Diabetologia · doi:10.1007/s00125-016-4022-4 · Cited by 223 · cited 2×
“Reviews and collections of papers reflecting the progress of the AP field are published regularly (2,3).”
BackgroundOutcome measures for artificial pancreas clinical trials: a consensus report
Maahs, D. M., Buckingham, B. A., Castle, J. R., Cinar, A., Damiano, E. R., Dassau, E., DeVries, J. H., Doyle, F. J., Griffen, S. C., Haidar, A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2716 · Cited by 211 · cited 1×
“Primary outcome was the percent time spent between 70 and 180 mg/dL (22), with secondary outcomes focusing on the quality of glycemic control, including percent time spent between 70 and 140 mg/dL, average CGM, and total insulin used.”
BackgroundSelf-citation
Cited by
Items 101–179 of 179
Hall, R. M., Dyhrberg, S., McTavish, A., McTavish, L., Corley, B., & Krebs, J. D. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14630 · Cited by 10
“To our knowledge, the effect of heating the skin on the FSL-CGM has not been evaluated, but may be relevant to exercise or in hot environments.(21,22) CGM has been shown to improve diabetes control(23,24) while reducing hypoglycaemia and, if available and comfortable, is preferentially used rather than capillary finge…”
BackgroundEsefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Brinkmann, C. K., & Halle, M. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1515-8792 · Cited by 10
Carbohydrate Requirement for Exercise in Type 1 Diabetes: Effects of Insulin Concentration
Francescato, M. P., Ajčević, M., & Accardo, A. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819826962 · Cited by 9
“Closed-loop systems have the potential to ameliorate exercise management in patients with T1D,(60) recent algorithms having reduced the exposure to exercise-induced hypoglycemia.(61,62) The development of an “exercise smart” artificial pancreas, however, still remains a major hurdle,(63) physical activity having been…”
BackgroundJabari, M. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-40423-y · Cited by 11
“Only 10 37–44, 46 ,”
BackgroundResultInfluentialSemiadaptive Infusion Control of Medications With Excitatory Dose-Dependent Effects
Zhu, J., Jin, X., Bighamian, R., Kim, C., Shipley, S. T., & Hahn, J. (2018) · IEEE Transactions on Control Systems Technology · doi:10.1109/tcst.2018.2815551 · Cited by 7
“neuromuscular blockade [1]–[8].”
Olid-Cárdenas, M. J., Jurado, A. L., Monroy, G., Gómez‐Perea, A., Cano-Ortíz, A., Jiménez, A. B. A., García-Ruiz, A., Jiménez-Cuenca, P., César, M. J. P., & Gea, I. L. (2024) · Nutrients · doi:10.3390/nu16142210 · Cited by 8
“In another 60 h ski camp, with the challenge of sports activity and low temperatures, 20 children showed a trend towards a higher TBR during the camp with the Control-IQ system (median 3.80% vs. 1.40%, p = 0.057) [24].”
BackgroundInfluentialvan Weenen, E., Banholzer, N., Föll, S., Züger, T., Fontana, F. Y., Skroče, K., HAYES, C. A., Kraus, M., Feuerriegel, S., Lehmann, V. F., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15147 · Cited by 8
“Studies showed improved time in range overnight and during exercise with AID systems,(35,36) even under demanding environmental conditions and without pre-planning of exercise.(37,38) An alternative to AID systems has been suggested by an ‘untethered’ approach with a hybrid regimen of injected insulin and continuous s…”
BackgroundMetabolic Models, in Silico Trials, and Algorithms
Çınar, A., Basu, A., Bequette, B. W., Breton, M. D., Buckingham, B. A., Cengiz, E., Cobelli, C., Dassau, E., Doyle, F. J., Fabris, C., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.18800.ac · Cited by 5
Self-citationSeckold, R., Smart, C. E., O'Neal, D. N., Riddell, M. C., Rafferty, J., Morrison, D., Obeyesekere, V. R., Gooley, J., Paldus, B., Valkenborghs, S. R., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0254 · Cited by 6
Esefeld, K., Heinicke, V., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Brinkmann, C. K., & Halle, M. (2020) · Ernährung & Medizin · doi:10.1055/a-1126-9975 · Cited by 4
Esefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Halle, M., & Brinkmann, C. K. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1946-3768 · Cited by 7
Decision Support Systems and Closed Loop
Nimri, R., Piper, M. M., Pinsker, J. E., & Dassau, E. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.2504 · Cited by 5
Use of Machine Learning and Hybrid Closed Loop Insulin Delivery at Diabetes Camps
TAYLOR, K., & Forlenza, G. P. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0026 · Cited by 5
“16,17 There have been further CL studies in prepubertal youth and adolescents in supervised outpatient settings that implemented physical activity.”
Self-citationWang, Q., Li, X., Zhang, W., Wang, H., Tang, J., Ding, Y., Zheng, X., & Luo, S. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251350210 · Cited by 4
Metabolic Models, in Silico Trials, and Algorithms
Çınar, A., Basu, A., Bequette, B. W., Breton, M. D., Buckingham, B. A., Cengiz, E., Cobelli, C., Dassau, E., Doyle, F. J., Fabris, C., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251338300 · Cited by 10
“37,38 Significant progress continues to be made in all these aspects.”
Self-citationThe Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations
Yardley, J. E. (2019) · Open Access Journal of Sports Medicine · doi:10.2147/oajsm.s149257 · Cited by 7
“Most studies involving single hormone closed-loop systems have found similar results in sensor-augmented insulin pump therapy (where the user makes insulin delivery decisions) with respect to time in target for blood glucose concentration, and time in hypoglycemia.(83,84,87) Conversely, dual hormone closed-loop system…”
Automated closed-loop insulin delivery: system components, performance, and limitations
Rashid, M. M., Hajizadeh, I., Samadi, S., Sevil, M., Hobbs, N., Brandt, R., & Çınar, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00015-6 · Cited by 9
Esefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Brinkmann, C. K., & Halle, M. (2020) · Diabetologie und Stoffwechsel · doi:10.1055/a-1193-3901 · Cited by 5
Hybrid Closed-Loop Insulin Delivery Systems for People With Type 1 Diabetes
Service, C. H. T. A. (2021) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2021.50 · Cited by 4
Esefeld, K., Heinicke, V., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Brinkmann, C. K., & Halle, M. (2020) · Der Diabetologe · doi:10.1007/s11428-020-00610-1 · Cited by 3
New technical approach to the diabetes therapy
Dovč, K., & Battelino, T. (2020) · Minerva Pediatrics · doi:10.23736/s0026-4946.20.05865-x · Cited by 3
Sawyer, A., Forlenza, G. P., & Wadwa, R. P. (2025) · Expert Review of Medical Devices · doi:10.1080/17434440.2025.2585061 · Cited by 2
“The system was also tested during exercise with studies in adolescents during ski camp and was found to be safe and improve glycemic outcomes during prolonged and intense exercise [61,62].”
Self-citationFerguson, A. M., & Lin, A. C. (2024) · Annals of Biomedical Engineering · doi:10.1007/s10439-024-03529-6 · Cited by 3
Early Stages of Automated Insulin Delivery
Zisser, H., Hovorka, R., Basu, A., Battelino, T., Boughton, C. K., Breton, M. D., Buckingham, B. A., Brown, S. A., Cherñavvsky, D. R., Dassau, E., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.18802.hz · Cited by 3
“DiAs has since been used in over 20 clinical trials, on four continents, 50,51 from supervised hotel studies to the ski slopes, 41,52 for up to six months per user.”
Self-citationHow Important Is a Closed‐Loop Artificial Pancreas?
Foltyński, P. (2018) · Artificial Organs · doi:10.1111/aor.13338 · Cited by 2
Exercise, Sleep, and Type 1 Diabetes
Jacobs, P. G., & Reddy, R. K. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816658-1.00015-6 · Cited by 2
Colmegna, P. H., Bianchi, F. D., & Sánchez‐Peña, R. (2021) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.23919/acc50511.2021.9483386 · Cited by 2
Insulin Pumps and Artificial Pancreas
Taleb, N., Gingras, V., & RABASA-LHORET, R. P. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65407-7 · Cited by 3
Resistive Exercise versus Acupressure on Blood Glucose Level in Type 2 Diabetes
AHMED, M. S. A. A. S. A. Y., & NASIF, P. D. A. E. N. E. H. N. L. (2021) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2021.203295 · Cited by 1
The ‘Designer’ Artificial Pancreas: How Does Current Technology Mimic Pancreatic Physiology?
Daly, L. A. (2025) · Cureus · doi:10.7759/cureus.86770 · Cited by 2
“Likewise, more recent large-scale clinical trials have demonstrated similar improvements across a range of populations, including pregnant women [25], children [26] and adults with sub-optimally controlled diabetes [27].”
Artificial Pancreas: The First 20 Years
Doyle, F. J., & Kovatchev, B. P. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251330920 · Cited by 5
Self-citationMoser, O., Becker, U., van den Boom, L., Brinkmann, C. K., Danne, T., Fröhlich-Reiterer, E. E., Gehr, B., Kietaibl, A.-T., Köhler, G., Kreß, S., et al. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-025-02663-y · Cited by 1
Esefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Halle, M., & Brinkmann, C. K. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1901-0690 · Cited by 1
Esefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Halle, M., & Brinkmann, C. K. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-2076-0130 · Cited by 1
Diabetes, Sport und Bewegung: Therapeutische Optionen und praktische Empfehlungen für die Umsetzung
Esefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Halle, M., & Brinkmann, C. K. (2023) · Diabetes aktuell · doi:10.1055/a-2208-5579 · Cited by 2
Esefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Halle, M., & Brinkmann, C. K. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01171-3 · Cited by 1
“[34, 35, 36, 37].”
Halle, M., Brinkmann, C. K., Esefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., & Gehr, B. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2312-0420 · Cited by 1
Baagar, K. A. M., Ali, H. A., Ata, F., Mohamud, K., Al-Naimi, N., Alsaud, A., Al-Sharshani, H., Abd-Alrazaq, A. A., Ahmed, A., Aziz, S., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112353 · Cited by 1
Early Stages of Automated Insulin Delivery
Zisser, H., Hovorka, R., Basu, A., Battelino, T., Boughton, C. K., Breton, M. D., Buckingham, B. A., Brown, S. A., Cherñavvsky, D. R., Dassau, E., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251335685 · Cited by 2
“DiAs has since been used in over 20 clinical trials, on four continents, 50,51 from supervised hotel studies to the ski slopes, 41,52 for up to six months per user.”
Self-citationEsefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Halle, M., & Brinkmann, C. K. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01039-y · Cited by 1
Lv, D., Garcia‐Tirado, J., & Fabris, C. (2018) · OBM Transplantation · doi:10.21926/obm.transplant.1803019 · Cited by 2
Multivariable AP with adaptive control
Hajizadeh, I., Rashid, M. M., Samadi, S., Sevil, M., Hobbs, N., Brandt, R., & Çınar, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815655-1.00012-0 · Cited by 2
Artificial pancreas in pediatrics
Forlenza, G. P., Messer, L. H., Maahs, D. M., & Cherñavvsky, D. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815655-1.00020-x · Cited by 1
Self-citationMultiple-signal artificial pancreas systems
Patek, S. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815655-1.00019-3 · Cited by 3
Müller-Korbsch, M., Frühwald, L., Heer, M., Fangmeyer-Binder, M., Reinhart-Mikocki, D., & Fasching, P. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819879419 · Cited by 1
“In a study by Breton et al,17 investigators managed glucose control in the sensor-augmented pump group by reducing the basal insulin doses by approximately 66% to maintain a time in target range of 70 to 180 mg/dL.”
BackgroundMesterséges hasnyálmirigy – A cukorbetegség automatikus kezelése mérnöki megközelítéssel
Kovács, L., Eigner, G., Czako, B. G., Siket, M., Almássy, Z., Kocsis, G., & Barkai, L. (2019) · Diabetologia Hungarica · doi:10.24121/dh.2019.21 · Cited by 1
Esefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Brinkmann, C. K., & Halle, M. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00745-9 · Cited by 3
New Contributions Towards Meal and Exercise Announcement-Free Artificial Pancreas Systems
Sala-Mira, I. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/192684 · Cited by 3
Artificial Pancreas: The First 20 Years*
Doyle, F. J., & Kovatchev, B. P. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0134 · Cited by 4
“33 42 In 2014, NIDDK issued a program announcement titled “ Advanced Clinical Trials to test Arti fi cial Pancreas Device Systems in Type 1 Diabetes (UC4).”
Self-citationBeim Skisport schlägt Hybrid Closed Loop die reine Hypoglykämie-Abschaltung
Forst, T. M. (2018) · Info Diabetologie · doi:10.1007/s15034-018-1267-7
Integrating the clinical and engineering aspects of closed-loop control: the Virginia experience
Brown, S. A., Anderson, S. M., Breton, M. D., Cherñavvsky, D. R., DeBoer, M. D., & Kovatchev, B. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815655-1.00017-x
Self-citationBasal Insulin Adjustments and Continuous Glucose Monitoring During Exercise in Type 1 Diabetes
Zaharieva, D. P. (2018) · YorkSpace (York University)
Scott, S. N., Riddell, M. C., & Yardley, J. E. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-33376-8_25
The dawn of automated insulin delivery: from promise to product
Nally, L. M., & Sherr, J. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00016-8
Mason, M. A., Russ, A. C., Tierney, R., & Mansell, J. L. (2021) · International Journal of Athletic Therapy & Training · doi:10.1123/ijatt.2020-0109
Diabetes Technology and Therapy in the Pediatric Age Group
Maahs, D. M., Ekhlaspour, L., & Shalitin, S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.2508
Self-citationEstrategias de control avanzadas para páncreas artificial
Fushimi, E. (2021) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/133534
Proceedings of 21st ISPAD science school for physicians 2022
Santos, T. J. D., Chobot, A. P., Piona, C. A., Dovč, K., Biester, T., Gajewska, K. A., de Beaufort, C. E., Šumník, Z., & Petruželková, L. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13412 · Cited by 2
Session Three: Innovating Beyond Glucose Control in Diabetes Care
Michel, L. (2017) · EMJ Diabetes · doi:10.33590/emjdiabet/10314488
Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
Patel, P. M., Abaniel, R. M., Dogra, N., Lo, C. B., Frazzitta, M. A., & Virdi, N. S. (2023) · doi:10.2337/figshare.22714573.v1
Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
Patel, P. M., Abaniel, R. M., Dogra, N., Lo, C. B., Frazzitta, M. A., & Virdi, N. S. (2023) · doi:10.2337/figshare.22714573
Fully automated insulin delivery: artificial pancreas
Barkai, L. (2023) · Egészségtudományi Közlemények · doi:10.32967/etk.2023.009
“Other studies have examined the effectiveness of the regulations in the case of exercise of varying intensity and unpredicted, large amounts of food intake, with favourable results [29, 30].”
Controlling Human Physiology via Drugs and Devices
Hahn, J., & Howsmon, D. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14081-5.00009-x
Data analytic models of patients dependent on insulin treatment
Adetuyi, T. G., Adetuyi, B. O., Okunlola, F. O., Oni, P. G., Olajide, P. A., Omolehin, P. T., Adetunji, C. O., Adetunji, M. C., & Oyewole, O. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95686-4.00017-4
Zeng, B., Gao, L., Yang, Q., Jia, H., & Sun, F. (2025) · doi:10.2337/figshare.23700345
Halle, M., Brinkmann, C. K., Esefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., & Gehr, B. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2500-1026
Esefeld, K., Kreß, S., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Halle, M., & Brinkmann, C. K. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01345-7 · Cited by 1
Elbarbary, N. S., & Ismail, E. A. R. (2024) · Figshare · doi:10.6084/m9.figshare.24320090
Kang, S. L., Hwang, Y. N., Kwon, J. Y., & Kim, S. M. (2024) · Figshare · doi:10.6084/m9.figshare.26552224
Elbarbary, N. S., & Ismail, E. A. R. (2023) · Figshare · doi:10.6084/m9.figshare.24319951
Halle, M., Brinkmann, C., Esefeld, K., Kreß, S., Becker, U., MOSER, O., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., et al. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-8335 · Cited by 1
Roba, A. A., Shah, G. H., Mase, W. A., & Apenteng, B. A. (2026) · Research Square · doi:10.21203/rs.3.rs-8942270/v1
Esefeld, K., Kreß, S., Becker, U., Moser, O., Behrens, M., Zimmer, P., Stümvoll, M., Thurm, U., Gehr, B., Halle, M., et al. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01447-w
A Review on Hybrid Closed Loop Insulin Delivery System
Kuralarasan, S. G. (2025) · Advances in Applied Biological Research · doi:10.48165/aabr.2025.2.2.04
Molveau, J. (2025) · theses.fr (ABES) · doi:10.70675/bd2bda54z3647z4fc4z9eebz1d71ad50a8b2
Hjortdahl, F. J., Årsand, E., & Joakimsen, R. M. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02297-9
Moser, O., Becker, U., van den Boom, L., Brinkmann, C. K., Danne, T., Fröhlich-Reiterer, E. E., Gehr, B., Kietaibl, A.-T., Köhler, G., Kreß, S., et al. (2026) · Diabetologie und Stoffwechsel · doi:10.1055/a-2727-1063
Al-Reshawee, F., & Alburkat, H. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16100514
“…glucose monitoring, predictive algorithms, and automated insulin delivery, has demonstrated in multiple clinical trials that real-time feedback-controlled hormone delivery can replicate the responsiveness of biological endocrine systems more realistically than fixed dose regimens [31,32,34,49].”
Metadata
- Authors
- Breton, M. D., Cherñavvsky, D. R., Forlenza, G. P., DeBoer, M. D., Robic, J., Wadwa, R. P., Messer, L. H., Kovatchev, B. P., & Maahs, D. M.
- Affiliations
- University of Virginia (US)
- University of Colorado Denver (US)
- Corresponding author
- Breton, Marc D.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-30
- Volume
- 40
- Issue
- 12
- Pages
- 1644-1650
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC5711335
- OpenAlex
- W2752733073
- Cited by
- 179
- References
- 31
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 11 · 2023: 18 · 2022: 10 · 2021: 17 · 2020: 36 · 2019: 31 · 2018: 28 · 2017: 3
- FWCI
- 21.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (NIH-DP3-DK106826)
- University of Colorado Foundation
- Children’s Diabetes Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, feedback control, artificial pancreas, adolescents, prolonged exercise, skiing, glycemic control, hypoglycemia, time in range, sensor-augmented pump, cold exposure, altitude, winter sports
- MeSH terms
- Adolescent, Blood Glucose, Child, Cold Temperature, Colorado, Diabetes Mellitus, Type 1, Glycated Hemoglobin, Humans, Hypoglycemia, Seasons, Skiing, Virginia, Blood Glucose Self-Monitoring, Exercise, Body Mass Index, Treatment Outcome, Pancreas, Artificial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.